The pharmaceutical industry has steadily transitioned away from paper-based clinical projects and embraced the use of electronic data capture (EDC) systems and tools to run Phase I, II, III and IV studies. The options available to the various industry groups (biotech startups, contract research organizations, small, medium and large pharmaceutical firms) have changed over the past several years, as have the companies involved in delivering EDC applications and services.
In general, industry can choose from the following core options:
On-site or on-demand ...
Continue Reading →
4
JAN
JAN
0